Abstract
There is controversy as to whether zidovudine (ZDV) induces a mitochondrial myopathy that is distinguishable from human immunodeficiency virus (HIV)-associated myopathy in ZDV-naive patients. Mitochondrial abnormalities were evaluated in skeletal muscle obtained from 18 HIV-positive, ZDV-exposed patients, and 9 who were drug naive. All patients had clinical myopathy, and underwent neuromuscular evaluation with information recorded on timing and dosage of ZDV. All underwent muscle biopsies and samples were examined without knowledge of clinical history of ZDV status. Biopsy samples were evaluated by light and electron microscopy. Mitochondrial abnormalities were seen in ZDV-treated and-naive groups, and did not correlate with ZDV exposure or cumulative ZDV dosage. Mitochondrial abnormalities displayed significant correlation with the presence and severity of myofiber degeneration on biopsy, regardless of ZDV status. As mitochondrial abnormalities reflect myofiber degeneration, present in both patient groups, they may not be used as evidence of primary mitochondrial dysfunction. The etiology of myofiber degeneration in patients with HIV infection, whether ZDV-exposed ornaive, remains unclear.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arnaudo E, Dalakas M, Shanske S, Moraes C, DiMauro S, Schon E (1991) Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 337: 508–510
Bessen L, Greene J, Louie E, Seitzman P, Weinberg H (1988) Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC. N Engl J Med 318: 708
Chalmers A, Greco C, Miller R (1991) Prognosis in AZT myopathy. Neurology 41: 1181–1184
Chariot P, Gherardi R (1991) Partial cytochrome c oxidase deficiency and cytoplasmic bodies in patients with zidovudine myopathy. Neuromusc Disord 1: 357–363
Dalakas M, Pezeshkpour G, Gravell M, Sever J (1986) Polymyositis associated with AIDS retrovirus. JAMA 17: 2381–2385
Dalakas M, Illa I, Pezeshkpour G, Laukaitis J, Cohen B, Griffin J (1990) Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 322: 1098–1105
Gherardi R (1994) Skeletal muscle involvement in HIV-infected patients. Neuropathol Appl Neurobiol 20: 232–237
Gherardi R, Florea-Strat A, Fromont G, Poron F, Sabourin J-C, Authier J (1994) Cytokine expression in the muscle of HIV-infected patients: evidence for interleukin-1 alpha accumulation in mitochondria of AZT fibers. Ann Neurol 36: 752–758
Gonzales M, Olney R, So Y, Greco C, McQuinn B, Miller R, DeArmonds S (1988) Subacute structural myopathy associated with human immunodeficiency virus infection. Arch Neurol 45: 585–587
Herzberg N, Zorn I, Zwart R, Bolhuis P (1992) Major growth reduction and minor decrease in mitochondrial enzyme activity in cultured human muscle cells after exposure to zidovudine. Muscle Nerve 15: 706–710
Kahn J, Lagakos S, Richman D, Cross A, Pettinelli C, Liou SH, Brown M, Volberding P, Crumpacker C, Beall G, Sacks H, Merigan T, Beltangady M, Smaldone L, Dolin R, the NIAID AIDS Clinical Trials Group (1992) A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. N Engl J Med 327: 581–587
Mastaglia F, Ojeda V (1985) Inflammatory myopathies, part 2. Ann Neurol 17: 317–323
Mhiri C, Baudrimont M, Bonne G, Geny C, Degoul F, Marsac C, Roullet E, Gherardi R (1991) Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction. Ann Neurol 29: 606–614
Olson W, Engel W, Walsh G, Einengler R (1972) Oculocraniosomatic neuromuscular disease with ragged red fibers. Arch Neurol 26: 193–211
Pezeshkpour G, Illa I, Dalakas M (1991) Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies. Hum Pathol 22: 1281–1288
Schröder J, Bertram M, Schnabel R, Pfaff U (1992) Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine. Acta Neuropathol 85: 39–47
Simpson D, Bender A (1988) HIV-associated myopathy. Analysis of 11 patients. Ann Neurol 24: 79–84
Simpson D, Olney R (1992) Peripheral neuropathies associated with human immunodeficiency virus infection. Neurol Clin 10: 685–711
Simpson D, Citak K, Godfrey E, Godbold J, Wolfe D (1993) Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished? Neurology 43: 971–976
Snider W, Simpson D, Nielsen S, Gold J, Metroka C, Posner J (1983) Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 14: 403–418
Weissman J, Constantinitis I, Hudgins P, Wallace D (1992) 31P magnetic resonance spectroscopy suggests impaired mitochondrial function in AZT-treated HIV-infected patients. Neurology 42: 619–623
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morgello, S., Wolfe, D., Godfrey, E. et al. Mitochondrial abnormalities in human immunodeficiency virus-associated myopathy. Acta Neuropathol 90, 366–374 (1995). https://doi.org/10.1007/BF00315010
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00315010